메뉴 건너뛰기




Volumn 112, Issue 5, 2014, Pages 918-923

Organ-specific bleeding patterns of anticoagulant therapy: Lessons from clinical trials

Author keywords

Stroke prevention; Thrombosis; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; BLOOD CLOTTING FACTOR 10A; DABIGATRAN; EDOXABAN; PROTHROMBIN A; RIVAROXABAN; THROMBOPLASTIN; WARFARIN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A INHIBITOR; VITAMIN K GROUP;

EID: 84908543945     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-04-0346     Document Type: Article
Times cited : (58)

References (31)
  • 1
    • 34347394385 scopus 로고    scopus 로고
    • Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
    • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
    • (2007) Ann Intern Med , vol.146 , pp. 857-867
    • Hart, R.G.1    Pearce, L.A.2    Aguilar, M.I.3
  • 2
    • 0037145826 scopus 로고    scopus 로고
    • Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis
    • van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. J Am Med Assoc 2002; 288: 2441-2448.
    • (2002) J Am Med Assoc , vol.288 , pp. 2441-2448
    • van Walraven, C.1    Hart, R.G.2    Singer, D.E.3
  • 3
    • 84888400659 scopus 로고    scopus 로고
    • Vitamin K antagonists in heart disease: Current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
    • De Caterina R, Husted S, Wallentin L, et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013; 110: 1087-1107.
    • (2013) Thromb Haemost , vol.110 , pp. 1087-1107
    • De Caterina, R.1    Husted, S.2    Wallentin, L.3
  • 4
    • 79952301326 scopus 로고    scopus 로고
    • Apixaban in patients with atrial fibrillation
    • Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364: 806-817.
    • (2011) N Engl J Med , vol.364 , pp. 806-817
    • Connolly, S.J.1    Eikelboom, J.2    Joyner, C.3
  • 5
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 6
    • 84888362796 scopus 로고    scopus 로고
    • Edoxaban versus warfarin in patients with atrial fibrillation
    • Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013; 369: 2093-2104.
    • (2013) N Engl J Med , vol.369 , pp. 2093-2104
    • Giugliano, R.P.1    Ruff, C.T.2    Braunwald, E.3
  • 7
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-992.
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 8
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-891.
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 9
    • 84896117299 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials
    • Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955-962.
    • (2014) Lancet , vol.383 , pp. 955-962
    • Ruff, C.T.1    Giugliano, R.P.2    Braunwald, E.3
  • 10
    • 84878535107 scopus 로고    scopus 로고
    • Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation
    • Wallentin L, Lopes RD, Hanna M, et al. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation 2013; 127: 2166-2176.
    • (2013) Circulation , vol.127 , pp. 2166-2176
    • Wallentin, L.1    Lopes, R.D.2    Hanna, M.3
  • 11
    • 84888415701 scopus 로고    scopus 로고
    • Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
    • Gallego P, Roldan V, Marin F, et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 2013; 110: 1189-1198.
    • (2013) Thromb Haemost , vol.110 , pp. 1189-1198
    • Gallego, P.1    Roldan, V.2    Marin, F.3
  • 12
    • 70349657518 scopus 로고    scopus 로고
    • Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: A systematic review
    • Wan Y, Heneghan C, Perera R, et al. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circulation Cardiovasc Qual Outcom 2008; 1: 84-91.
    • (2008) Circulation Cardiovasc Qual Outcom , vol.1 , pp. 84-91
    • Wan, Y.1    Heneghan, C.2    Perera, R.3
  • 13
    • 84889886957 scopus 로고    scopus 로고
    • Effect of warfarin on intracranial haemorrhage incidence and fatal outcomes
    • Witt DM, Delate T, Hylek EM, et al. Effect of warfarin on intracranial haemorrhage incidence and fatal outcomes. Thrombosis Res 2013; 132: 770-775.
    • (2013) Thrombosis Res , vol.132 , pp. 770-775
    • Witt, D.M.1    Delate, T.2    Hylek, E.M.3
  • 14
    • 84904597072 scopus 로고    scopus 로고
    • Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: Results from the ROCKET AF trial
    • Piccini JP, Hellkamp AS, Lokhnygina Y, et al. Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial. J Am Heart Assoc 2014; 3: e000521.
    • (2014) J Am Heart Assoc , vol.3
    • Piccini, J.P.1    Hellkamp, A.S.2    Lokhnygina, Y.3
  • 15
    • 79955084921 scopus 로고    scopus 로고
    • International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy
    • Gulati G, Hevelow M, George M, et al. International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. Arch Pathol Lab Med 2011; 135: 490-494.
    • (2011) Arch Pathol Lab Med , vol.135 , pp. 490-494
    • Gulati, G.1    Hevelow, M.2    George, M.3
  • 16
    • 84876010146 scopus 로고    scopus 로고
    • Dabigatran attenuates thrombin generation to a lesser extent than warfarin: Could this explain their differential effects on intracranial haemorrhage and myocardial infarction?
    • Dale B, Eikelboom JW, Weitz JI, et al. Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial haemorrhage and myocardial infarction? J Thrombosis Thrombol 2013; 35: 295-301.
    • (2013) J Thrombosis Thrombol , vol.35 , pp. 295-301
    • Dale, B.1    Eikelboom, J.W.2    Weitz, J.I.3
  • 17
    • 29244463365 scopus 로고    scopus 로고
    • Astrocyte-endothelial interactions at the blood-brain barrier
    • Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Rev Neurosci 2006; 7: 41-53.
    • (2006) Nature Rev Neurosci , vol.7 , pp. 41-53
    • Abbott, N.J.1    Ronnback, L.2    Hansson, E.3
  • 18
    • 84888292079 scopus 로고    scopus 로고
    • Brain regulation of thrombosis and haemostasis: From theory to practice
    • Fisher MJ. Brain regulation of thrombosis and haemostasis: from theory to practice. Stroke 2013; 44: 3275-3285.
    • (2013) Stroke , vol.44 , pp. 3275-3285
    • Fisher, M.J.1
  • 19
    • 77957988717 scopus 로고    scopus 로고
    • Prevalence and risk factors of cerebral microbleeds: An update of the Rotterdam scan study
    • Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010; 41 (10 Suppl): S103-S106.
    • (2010) Stroke , vol.41 , Issue.10 , pp. S103-S106
    • Poels, M.M.1    Vernooij, M.W.2    Ikram, M.A.3
  • 20
    • 60549083975 scopus 로고    scopus 로고
    • Cerebral microbleeds are a risk factor for warfarin-related intracerebral haemorrhage
    • Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral haemorrhage. Neurology 2009; 72: 171-176.
    • (2009) Neurology , vol.72 , pp. 171-176
    • Lee, S.H.1    Ryu, W.S.2    Roh, J.K.3
  • 21
    • 51649110437 scopus 로고    scopus 로고
    • Association between cerebral microbleeds on T2*-weighted MR images and recurrent haemorrhagic stroke in patients treated with warfarin following ischemic stroke
    • Ueno H, Naka H, Ohshita T, et al. Association between cerebral microbleeds on T2*-weighted MR images and recurrent haemorrhagic stroke in patients treated with warfarin following ischemic stroke. Am J Neuroradiol 2008; 29: 1483-1486.
    • (2008) Am J Neuroradiol , vol.29 , pp. 1483-1486
    • Ueno, H.1    Naka, H.2    Ohshita, T.3
  • 22
    • 58149357106 scopus 로고    scopus 로고
    • Experimental model of warfarin-associated intracerebral haemorrhage
    • Foerch C, Arai K, Jin G, et al. Experimental model of warfarin-associated intracerebral haemorrhage. Stroke 2008; 39: 3397-3404.
    • (2008) Stroke , vol.39 , pp. 3397-3404
    • Foerch, C.1    Arai, K.2    Jin, G.3
  • 23
    • 76749165687 scopus 로고    scopus 로고
    • Kinetics of hematoma expansion in murine warfarin-associated intracerebral haemorrhage
    • Illanes S, Zhou W, Heiland S, et al. Kinetics of hematoma expansion in murine warfarin-associated intracerebral haemorrhage. Brain Res 2010; 1320: 135-142.
    • (2010) Brain Res , vol.1320 , pp. 135-142
    • Illanes, S.1    Zhou, W.2    Heiland, S.3
  • 24
    • 80053978431 scopus 로고    scopus 로고
    • Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral haemorrhage
    • Lauer A, Cianchetti FA, Van Cott EM, et al. Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral haemorrhage. Circulation 2011; 124: 1654-1662.
    • (2011) Circulation , vol.124 , pp. 1654-1662
    • Lauer, A.1    Cianchetti, F.A.2    Van Cott, E.M.3
  • 25
    • 84875232430 scopus 로고    scopus 로고
    • Intracerebral haemorrhage associated with antithrombotic treatment: Translational insights from experimental studies
    • Lauer A, Pfeilschifter W, Schaffer CB, et al. Intracerebral haemorrhage associated with antithrombotic treatment: translational insights from experimental studies. Lancet Neurol 2013; 12: 394-405.
    • (2013) Lancet Neurol , vol.12 , pp. 394-405
    • Lauer, A.1    Pfeilschifter, W.2    Schaffer, C.B.3
  • 26
    • 84880276047 scopus 로고    scopus 로고
    • Novel oral anticoagulants in gastroenterology practice
    • Desai J, Granger CB, Weitz JI, et al. Novel oral anticoagulants in gastroenterology practice. Gastrointest Endoscopy 2013; 78: 227-239.
    • (2013) Gastrointest Endoscopy , vol.78 , pp. 227-239
    • Desai, J.1    Granger, C.B.2    Weitz, J.I.3
  • 27
    • 84869109465 scopus 로고    scopus 로고
    • Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans
    • Bathala MS, Masumoto H, Oguma T, et al. Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans. Drug Metabol Disp 2012; 40: 2250-2255.
    • (2012) Drug Metabol Disp , vol.40 , pp. 2250-2255
    • Bathala, M.S.1    Masumoto, H.2    Oguma, T.3
  • 28
    • 38749131205 scopus 로고    scopus 로고
    • The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans
    • Blech S, Ebner T, Ludwig-Schwellinger E, et al. The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans. Drug Metabol Disp 2008; 36: 386-399.
    • (2008) Drug Metabol Disp , vol.36 , pp. 386-399
    • Blech, S.1    Ebner, T.2    Ludwig-Schwellinger, E.3
  • 29
    • 58149458160 scopus 로고    scopus 로고
    • Apixaban metabolism and pharmacokinetics after oral administration to humans
    • Raghavan N, Frost CE, Yu Z, et al. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metabol Disp 2009; 37: 74-81.
    • (2009) Drug Metabol Disp , vol.37 , pp. 74-81
    • Raghavan, N.1    Frost, C.E.2    Yu, Z.3
  • 30
    • 66449099711 scopus 로고    scopus 로고
    • Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans
    • Weinz C, Schwarz T, Kubitza D, et al. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans. Drug Metabol Disp 2009; 37: 1056-1064.
    • (2009) Drug Metabol Disp , vol.37 , pp. 1056-1064
    • Weinz, C.1    Schwarz, T.2    Kubitza, D.3
  • 31
    • 79958126202 scopus 로고    scopus 로고
    • Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial
    • Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011; 123: 2363-2372.
    • (2011) Circulation , vol.123 , pp. 2363-2372
    • Eikelboom, J.W.1    Wallentin, L.2    Connolly, S.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.